JAK1/2 Inhibitor Ruxolitinib Controls a Case of Chilblain Lupus Erythematosus

J Invest Dermatol. 2016 Jun;136(6):1281-1283. doi: 10.1016/j.jid.2016.02.015. Epub 2016 Feb 23.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Female
  • Humans
  • Janus Kinase 1 / antagonists & inhibitors*
  • Janus Kinase 2 / antagonists & inhibitors*
  • Lupus Erythematosus, Cutaneous / drug therapy*
  • Pyrazoles / therapeutic use*
  • STAT Transcription Factors / antagonists & inhibitors
  • STAT Transcription Factors / physiology

Substances

  • INCB018424
  • Pyrazoles
  • STAT Transcription Factors
  • Janus Kinase 1
  • Janus Kinase 2